IFM Investors Pty Ltd Has $9.08 Million Holdings in Cardinal Health, Inc. $CAH

IFM Investors Pty Ltd grew its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 14.6% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 42,962 shares of the company’s stock after purchasing an additional 5,489 shares during the quarter. IFM Investors Pty Ltd’s holdings in Cardinal Health were worth $9,078,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Integrated Wealth Concepts LLC grew its holdings in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after acquiring an additional 280 shares during the period. Jones Financial Companies Lllp lifted its stake in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after purchasing an additional 14,034 shares during the period. Arrowstreet Capital Limited Partnership bought a new stake in shares of Cardinal Health during the 2nd quarter valued at about $1,935,000. Cerity Partners LLC grew its stake in Cardinal Health by 17.0% during the second quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after purchasing an additional 5,880 shares during the period. Finally, Nebula Research & Development LLC grew its stake in Cardinal Health by 34.4% during the second quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after purchasing an additional 2,646 shares during the period. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 0.4%

Shares of CAH opened at $238.79 on Friday. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $240.93. The business’s fifty day moving average is $208.22 and its 200 day moving average is $211.50. The stock has a market cap of $55.93 billion, a P/E ratio of 36.51, a P/E/G ratio of 1.17 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the previous year, the business posted $2.35 EPS. Cardinal Health’s quarterly revenue was up 11.0% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, analysts expect that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio is 31.50%.

Analyst Ratings Changes

Several equities analysts have issued reports on CAH shares. JPMorgan Chase & Co. dropped their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. Evercore reduced their price objective on shares of Cardinal Health from $260.00 to $240.00 and set an “outperform” rating for the company in a research report on Wednesday, April 8th. Bank of America lifted their price objective on shares of Cardinal Health from $240.00 to $260.00 and gave the company a “buy” rating in a research note on Thursday. Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. Finally, TD Cowen increased their target price on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Fifteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $247.80.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.